KRAS and adenocarcinoma: AKT1 has been identified as a candidate driver gene in adenocarcinoma (Foster et al. 2014) and has been identified as an important regulator of invasion and metastasis of lung cancer cells having KRAS or EGFR mutations (Rao et al. 2017).